These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 26330104

  • 1. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
    Ding J, Li M, Wan X, Jin X, Chen S, Yu C, Li Y.
    Sci Rep; 2015 Sep 02; 5():13729. PubMed ID: 26330104
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease.
    Huang R, Duan X, Liu X, Cao H, Wang Y, Fan J, Wang B.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1252-1258. PubMed ID: 30558790
    [Abstract] [Full Text] [Related]

  • 3. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1.
    Wang Y, Zhu K, Yu W, Wang H, Liu L, Wu Q, Li S, Guo J.
    Biochem Biophys Res Commun; 2017 Nov 04; 493(1):227-232. PubMed ID: 28899784
    [Abstract] [Full Text] [Related]

  • 4. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS, Kim SG, Kim YS, Jang SH, Kwon Y, Choi D, Huh T, Moon E, Ahn E, Seong JK, Kweon HS, Hwang GS, Lee DH, Cho KW, Koo SH.
    Mol Metab; 2022 Jan 04; 55():101402. PubMed ID: 34838715
    [Abstract] [Full Text] [Related]

  • 5. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
    Wang L, Sun M, Cao Y, Ma L, Shen Y, Velikanova AA, Li X, Sun C, Zhao Y.
    Arch Biochem Biophys; 2020 Nov 30; 695():108642. PubMed ID: 33098868
    [Abstract] [Full Text] [Related]

  • 6. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE, Ferreira DM, Afonso MB, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM.
    J Hepatol; 2013 Jan 30; 58(1):119-25. PubMed ID: 22902550
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathway.
    Chen L, Yu S, Hong S, Lin X, Zhu X, Cao X, Li Y, Xiao H.
    Drug Dev Res; 2023 Apr 30; 84(2):156-171. PubMed ID: 36541217
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis.
    BinMowyna MN, AlFaris NA, Al-Sanea EA, AlTamimi JZ, Aldayel TS.
    Arch Physiol Biochem; 2024 Jun 30; 130(3):300-315. PubMed ID: 35254877
    [Abstract] [Full Text] [Related]

  • 10. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
    Shan W, Gao L, Zeng W, Hu Y, Wang G, Li M, Zhou J, Ma X, Tian X, Yao J.
    Cell Death Dis; 2015 Jul 23; 6(7):e1833. PubMed ID: 26203862
    [Abstract] [Full Text] [Related]

  • 11. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice.
    Li X, Lian F, Liu C, Hu KQ, Wang XD.
    Sci Rep; 2015 Nov 26; 5():16774. PubMed ID: 26608583
    [Abstract] [Full Text] [Related]

  • 12. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy.
    Stacchiotti A, Grossi I, García-Gómez R, Patel GA, Salvi A, Lavazza A, De Petro G, Monsalve M, Rezzani R.
    Cells; 2019 Sep 08; 8(9):. PubMed ID: 31500354
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W, Lee JH, Kim SW, Kim JH, Bae SH, Kim M, Hwang D, Kim YS, Park T, Um SJ, Song BJ, Yoon SK.
    Int J Biochem Cell Biol; 2015 Jul 08; 64():265-76. PubMed ID: 25957914
    [Abstract] [Full Text] [Related]

  • 16. microRNA-141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP-activated protein kinase pathway in hepatocytes.
    Yousefi Z, Nourbakhsh M, Abdolvahabi Z, Ghorbanhosseini SS, Hesari Z, Yarahmadi S, Ezzati-Mobasser S, Seiri P, Borji M, Meshkani R, Malek M.
    J Cell Physiol; 2020 Feb 08; 235(2):880-890. PubMed ID: 31256424
    [Abstract] [Full Text] [Related]

  • 17. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
    Kim HJ, Joe Y, Yu JK, Chen Y, Jeong SO, Mani N, Cho GJ, Pae HO, Ryter SW, Chung HT.
    Biochim Biophys Acta; 2015 Jul 08; 1852(7):1550-9. PubMed ID: 25916635
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.
    Xu Y, Zhu Y, Hu S, Pan X, Bawa FC, Wang HH, Wang DQ, Yin L, Zhang Y.
    Mol Metab; 2021 Sep 08; 51():101244. PubMed ID: 33930596
    [Abstract] [Full Text] [Related]

  • 19. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
    Azar S, Udi S, Drori A, Hadar R, Nemirovski A, Vemuri KV, Miller M, Sherill-Rofe D, Arad Y, Gur-Wahnon D, Li X, Makriyannis A, Ben-Zvi D, Tabach Y, Ben-Dov IZ, Tam J.
    Mol Metab; 2020 Dec 08; 42():101087. PubMed ID: 32987186
    [Abstract] [Full Text] [Related]

  • 20. MiR-34a regulates mitochondrial content and fat ectopic deposition induced by resistin through the AMPK/PPARα pathway in HepG2 cells.
    Wen F, An C, Wu X, Yang Y, Xu J, Liu Y, Wang C, Nie L, Fang H, Yang Z.
    Int J Biochem Cell Biol; 2018 Jan 08; 94():133-145. PubMed ID: 29197627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.